AU2445900A - Regulation of anaesthesia - Google Patents

Regulation of anaesthesia Download PDF

Info

Publication number
AU2445900A
AU2445900A AU24459/00A AU2445900A AU2445900A AU 2445900 A AU2445900 A AU 2445900A AU 24459/00 A AU24459/00 A AU 24459/00A AU 2445900 A AU2445900 A AU 2445900A AU 2445900 A AU2445900 A AU 2445900A
Authority
AU
Australia
Prior art keywords
dsip
anaesthesia
delta
compound
anaesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24459/00A
Other languages
English (en)
Inventor
Michael Alkire
Jim Fallon
Richard Haier
Christopher John Douglas Pomfrett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Victoria University of Manchester
Original Assignee
Victoria University of Manchester
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Victoria University of Manchester, University of Manchester filed Critical Victoria University of Manchester
Publication of AU2445900A publication Critical patent/AU2445900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU24459/00A 1999-02-05 2000-02-01 Regulation of anaesthesia Abandoned AU2445900A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
GB9902469 1999-02-05
US12032699P 1999-02-17 1999-02-17
US60120326 1999-02-17
US15566199P 1999-09-24 1999-09-24
US60155661 1999-09-24
PCT/GB2000/000281 WO2000045832A2 (en) 1999-02-05 2000-02-01 Regulation of anaesthesia

Publications (1)

Publication Number Publication Date
AU2445900A true AU2445900A (en) 2000-08-25

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24459/00A Abandoned AU2445900A (en) 1999-02-05 2000-02-01 Regulation of anaesthesia

Country Status (15)

Country Link
EP (1) EP1148887A2 (tr)
JP (1) JP2002536337A (tr)
KR (1) KR20010101992A (tr)
CN (1) CN1346278A (tr)
AP (1) AP2001002245A0 (tr)
AU (1) AU2445900A (tr)
BR (1) BR0008046A (tr)
CA (1) CA2360124A1 (tr)
ID (1) ID30518A (tr)
IL (1) IL144572A0 (tr)
MX (1) MXPA01007949A (tr)
NO (1) NO20013795D0 (tr)
OA (1) OA11758A (tr)
TR (1) TR200102265T2 (tr)
WO (1) WO2000045832A2 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
KR20100056524A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 배합물 티모신 베타 ４ 및 델타 수면 유도 펩티드의 용도
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
NO20013795L (no) 2001-08-02
CN1346278A (zh) 2002-04-24
IL144572A0 (en) 2002-05-23
MXPA01007949A (es) 2003-06-04
OA11758A (en) 2005-07-19
JP2002536337A (ja) 2002-10-29
ID30518A (id) 2001-12-13
WO2000045832A2 (en) 2000-08-10
NO20013795D0 (no) 2001-08-02
KR20010101992A (ko) 2001-11-15
CA2360124A1 (en) 2000-08-10
TR200102265T2 (tr) 2001-12-21
AP2001002245A0 (en) 2001-09-30
BR0008046A (pt) 2001-11-06
EP1148887A2 (en) 2001-10-31
WO2000045832A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
US6562855B1 (en) Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist
Thiele et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats
JP5863650B2 (ja) 疼痛を処置するための方法
Kow et al. The effects of the TRH metabolite cyclo (His-Pro) and its analogs on feeding
JP2003529541A6 (ja) ＮＭＤＡ拮抗薬とα２アドレナリン作用薬とを含む麻酔製剤
US5432176A (en) Method of retarding the progression of chronic renal failure
Cunningham et al. Dissociation of experimentally induced drinking behavior by ibotenate injection into the median preoptic nucleus
AU2445900A (en) Regulation of anaesthesia
JP2009534360A (ja) アルファ−ケトグルタレートを含む組成物およびその筋性能を調節するための使用
Yaksh et al. Kinetic and safety studies on intrathecally infused recombinant-methionyl human brain-derived neurotrophic factor in dogs
Mazarati et al. Felbamate in experimental model of status epilepticus
Guarnieri et al. Subcutaneous implants of a cholesterol-triglyceride-buprenorphine suspension in rats
Feng et al. Selective effects of alfentanil on nociceptive-related neurotransmission in neonatal rat spinal cord
ZA200106256B (en) Regulation of anaesthesia.
US20030064932A1 (en) Methods of treatment comprising administration of Substance P
Collin et al. Feedback inhibition of met‐enkephalin release from the rat spinal cord in vivo
Mitchell et al. The long-term effect of epidural administration of butamben suspension on nerve injury-induced allodynia in rats
US20240189301A1 (en) Methods and compositions for maintaining opioid efficacy in the treatment of pain
Van Dijk et al. Changes in heart rate, mean arterial pressure, blood biochemistry, plasma glucose, plasma lactate and some plasma enzymes during sufentanil/halothane anaesthesia in horses
Zhou Role of glucoprivation, leptin and melanocortins in control of estrous cycles and food intake in Syrian hamsters
Kang Neurochemical and Behavioural Changes Foiiowing Propofol Anesthesia in the Rat.
Poli et al. Functional interactions between adenosine A1 and class II of metabotropic glutamate receptors in rat hippocampus
Jones Nora V. Bergasa
AU2001296493A1 (en) Use of neuropeptide-Y antagonists in treatment of alcoholism
WO2002028393A1 (en) Use of neuropeptide-y antagonists in treatment of alcoholism

Legal Events

Date Code Title Description
MK3 Application lapsed section 142(2)(c) - examination deferred under section 46 no request for examination